CD8A and neoplasm: However, studies have shown that the functional status of CD8+ T cells changes with tumor progression, and different stages of dysfunctional T cells, characterized by the expression of specific immune checkpoint molecules, are thought to be associated with distinct response rates to immune checkpoint inhibitors (40).